UNIVERSAL ELECTRONICS INC
For the period ended Sep 30, 2024. Filed Nov 7, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 7, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Notes to Consolidated Financial Statements
Note 1 —Basis of Presentation
In the opinion of management, the accompanying consolidated financial statements of Universal Electronics Inc. and its subsidiaries contain all the adjustments necessary for a fair presentation of financial position, results of operations and cash flows for the periods presented. All such adjustments are of a normal recurring nature, except for the impairment and restructuring charges, as described in notes 6 and 12 to the consolidated financial statements. Information and footnote disclosures normally included in financial statements, which are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"), have been condensed or omitted pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). As used herein, the terms "Company," "we," "us," and "our" refer to Universal Electronics Inc. and its subsidiaries, unless the context indicates to the contrary.
Our results of operations for the three and nine months ended September 30, 2024 are not necessarily indicative of the results to be expected for the full year. These financial statements should be read in conjunction with the "Risk Factors," "Management's Discussion and Analysis of Financial Condition and Results of Operations," "Quantitative and Qualitative Disclosures About Market Risk," and the "Financial Statements and Supplementary Data" included in Items 1A, 7, 7A, and 8, respectively, of our Annual Report on Form 10-K for the year ended December 31, 2023.
Estimates and Assumptions
The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. On an on-going basis, we evaluate our estimates and assumptions, including those related to revenue recognition; allowance for credit losses; inventory valuation; impairment of long-lived assets, intangible assets and goodwill; business combinations; income taxes and related valuation allowances and stock-based compensation expense. Actual results may differ from these assumptions and estimates, and they may be adjusted as more information becomes available. Any adjustment may be material.
Summary of Significant Accounting Policies
With the exception of the following policy, our significant accounting policies are unchanged from those disclosed in Note 2 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2023.
Stock-Based Compensation
We recognize the grant date fair value of stock-based compensation awards as expense in proportion to vesting during the derived service period, which ranges fromone tothree years. Forfeitures of stock-based awards are accounted for as they occur. Upon the exercise of stock options, the vesting of restricted stock awards or the vesting of performance stock awards, newly issued shares of our common stock are issued. Our stock-based compensation awards are made at the discretion of the Compensation Committee and are not timed or coordinated with the release of material, non-public information.
We determine the fair value of restricted stock awards with a service condition utilizing the average of the high and low trading prices of our common shares on the date they were granted.
The fair value of performance stock awards with a market condition is determined utilizing a Monte Carlo simulation model as of the grant date. The assumptions utilized in a Monte Carlo simulation model include the risk-free interest rate, expected volatility, term of the award and dividend yield. The risk-free interest rate over the expected term is equal to the prevailing U.S. Treasury note rate over the same period. Expected volatility is determined utilizing historical volatility. The dividend yield is assumed to bezero since we have not historically declared dividends and do not have any plans to declare dividends in the future.
The fair value of stock options granted to employees and directors is determined utilizing the Black-Scholes option pricing model. The assumptions utilized in the Black-Scholes model include the risk-free interest rate, expected volatility, expected life in years and dividend yield. The risk-free interest rate over the expected term is equal to the prevailing U.S. Treasury note rate over the same period. Expected volatility is determined utilizing historical volatility over a period of time equal to the expected life of the stock option. Expected life is computed utilizing historical exercise patterns and post-vesting behavior. The dividend yield is assumed to be zero since we have not historically declared dividends and do not have any plans to declare dividends in the future. See Note 14 for further information concerning stock-based compensation.
Recently Adopted Accounting Pronouncements
None.
Recent Accounting Updates Not Yet Effective
In November 2023, the FASB issued ASU 2023-07, "Segment Reporting – Improvements to Reportable Segments Disclosures." The guidance enhances disclosures of significant segment expenses by requiring the disclosure of significant segment expenses regularly provided to the chief operating decision maker, extends certain annual disclosures to interim periods, and permits more than one measure of segment profit or loss to be reported under certain conditions. All disclosure requirements are also required for companies with a single reportable segment. The guidance is effective in fiscal years beginning after December 15, 2023, and interim periods within fiscal years beginning after December 15, 2024. Early adoption of the guidance is permitted, including adoption in any interim periods for which financial statements have not been issued. The Company expects this ASU to only impact our disclosures, with no impact to our consolidated balance sheets, statements of operations or cash flows.
In December 2023, the FASB issued ASU 2023-09, "Income Taxes - Improvements to Tax Disclosures." The guidance expands disclosures in an entity’s income tax rate reconciliation table and regarding cash taxes paid both in the U.S. and foreign jurisdictions. The guidance will be effective for annual periods beginning after December 15, 2024. The Company is currently evaluating the guidance and its impact to the financial statements and related disclosures.
We have assessed all other ASUs issued but not yet adopted and concluded that those not disclosed are not relevant to the Company or are not expected to have a material impact.
Note 2 —Cash and Cash Equivalents
Cash and cash equivalents were held in the following geographic regions:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| North America | $2,179 | $8,460 |
| People's Republic of China ("PRC") | 10,701 | 11,102 |
| Asia (excluding the PRC) | 2,735 | 2,427 |
| Europe | 5,641 | 8,145 |
| South America | 5,031 | 12,617 |
| Total cash and cash equivalents | $26,287 | $42,751 |
Note 3 —Revenue and Accounts Receivable, Net
Revenue Details
The pattern of revenue recognition was as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2024 | 2023 |
| Goods and services transferred at a point in time | $85,186 | $83,855 | $235,572 | $249,908 |
| Goods and services transferred over time | 16,887 | 23,240 | 48,853 | 72,955 |
| Net sales | $102,073 | $107,095 | $284,425 | $322,863 |
Our net sales to external customers by geographic area were as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2024 | 2023 |
| United States | $25,833 | $31,737 | $71,455 | $97,892 |
| Asia (excluding PRC) | 20,785 | 20,107 | 57,893 | 66,508 |
| Europe | 22,583 | 22,529 | 60,837 | 68,598 |
| PRC | 17,747 | 19,049 | 49,560 | 49,082 |
| Latin America | 9,164 | 8,227 | 26,888 | 24,408 |
| Other | 5,961 | 5,446 | 17,792 | 16,375 |
| Total net sales | $102,073 | $107,095 | $284,425 | $322,863 |
Specific identification of the customer billing location was the basis used for attributing revenues from external customers to geographic areas.
Net sales to the following customers totaled more than 10% of our net sales:
| Three Months Ended September 30, | ||||
|---|---|---|---|---|
| 2024 | 2023 | |||
| $ (thousands) | % of Net Sales | $ (thousands) | % of Net Sales | |
| Daikin Industries Ltd. | $12,620 | 12.4% | $15,194 | 14.2% |
| Sony Corporation | $10,841 | 10.6% | $11,825 | 11.0% |
| Nine Months Ended September 30, | |||||||
|---|---|---|---|---|---|---|---|
| 2024 · 2023 | |||||||
| $ (thousands) · % of Net Sales · $ (thousands) · % of Net Sales | |||||||
| Daikin Industries Ltd. | $37,658 | 13.2% | $48,401 | 15.0% | |||
| Comcast Corporation | (1) | (1) | $34,436 | 10.7% | |||
(1)Sales associated with this customer did not total more than 10% of our net sales for the indicated period.
Accounts Receivable, Net
Accounts receivable, net were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Trade receivables, gross | $102,127 | $106,182 |
| Allowance for credit losses | (841) | (815) |
| Allowance for sales returns | (343) | (532) |
| Trade receivables, net | 100,943 | 104,835 |
| Other (1) | 5,686 | 7,761 |
| Accounts receivable, net | $106,629 | $112,596 |
(1)Other accounts receivable is primarily comprised of value added tax receivables, interest receivable and supplier rebate receivables.
Allowance for Credit Losses
Changes in the allowance for credit losses were as follows:
| (In thousands) | Nine Months Ended September 30, | |
|---|---|---|
| 2024 | 2023 | |
| Balance at beginning of period | $815 | $957 |
| Additions (reductions) to costs and expenses | 17 | 69 |
| Write-offs/Foreign exchange effects | 9 | (207) |
| Balance at end of period | $841 | $819 |
There were no significant customers that totaled more than 10% of our accounts receivable at September 30, 2024 or December 31, 2023.
Contract Liabilities
We have current and non-current contract liability balances primarily relating to our firmware update provisioning and digital rights management validation services. Contract liabilities are included within other accrued liabilities in our consolidated balance sheets.
Changes in the carrying amount of contract liabilities were as follows:
| (In thousands) · Three Months Ended September 30, · Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||
| Balance at beginning of period | $4,717 | $2,931 | $3,501 | $1,931 |
| Payments received | 981 | 862 | 4,444 | 4,314 |
| Revenue recognized | (1,697) | (1,001) | (3,922) | (3,453) |
| Foreign exchange effects | 31 | — | 9 | — |
| Balance at end of period | $4,032 | $2,792 | $4,032 | $2,792 |
Note 4 —Inventories
Inventories were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Raw materials | $24,275 | $32,794 |
| Components | 13,162 | 11,061 |
| Work in process | 5,164 | 3,827 |
| Finished goods | 46,338 | 40,591 |
| Inventories | $88,939 | $88,273 |
Significant Supplier
There were no purchases from suppliers that totaled more than 10% of our total inventory purchases for the three and nine months ended September 30, 2024 and 2023.
There were no trade payable balances to suppliers that totaled more than 10% of our total accounts payable at September 30, 2024 and December 31, 2023.
Note 5 —Long-lived Tangible Assets
Long-lived tangible assets by geographic area, which include property, plant, and equipment, net and operating lease right-of-use assets, were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| United States | $10,444 | $13,245 |
| PRC | 23,547 | 26,679 |
| Mexico | 6,612 | 9,227 |
| Vietnam | 8,820 | 10,089 |
| All other countries | 3,313 | 4,072 |
| Total long-lived tangible assets | $52,736 | $63,312 |
Property, plant, and equipment are shown net of accumulated depreciation of $166.8 million and $163.3 million at September 30, 2024 and December 31, 2023, respectively.
Depreciation expense was $3.0 million and $4.6 million for the three months ended September 30, 2024 and 2023, respectively. Depreciation expense was $9.7 million and $13.9 million for the nine months ended September 30, 2024 and 2023, respectively.
Note 6 —Goodwill and Intangible Assets, Net
Goodwill
During the nine months ended September 30, 2023, a decline in our financial performance, overall negative trend in the video service provider channel and an uncertain economic environment contributed to a significant decline in our market capitalization. We considered this to be an impairment trigger. We, therefore, performed a quantitative valuation analysis under an income approach to estimate our reporting unit's fair value. The income approach used projections of estimated operating results and cash flows that were discounted using a discount rate based on the weighted-average cost of capital. The main assumptions supporting the cash flow projections include, but are not limited to, revenue growth, margins, discount rate, and terminal growth rate. The financial projections reflect our best estimate of economic and market conditions over the projected period, including forecasted revenue growth, margins, capital expenditures, depreciation and amortization. In addition to our valuation analysis under an income approach, we also considered the implied control premium compared to our market capitalization. We determined that the implied control premium over our market capitalization to be substantial; therefore, we recorded an impairment charge of $49.1 million during the nine months ended September 30, 2023.
Intangible Assets, Net
The components of intangible assets, net were as follows:
| September 30, 2024 | December 31, 2023 | |||||
|---|---|---|---|---|---|---|
| (In thousands) | Gross (1) | AccumulatedAmortization (1) | Net | Gross (1) | AccumulatedAmortization (1) | Net |
| Capitalized software development costs | $2,511 | $(909) | $1,602 | $2,161 | $(421) | $1,740 |
| Customer relationships | 6,340 | (4,346) | 1,994 | 6,340 | (3,803) | 2,537 |
| Developed and core technology | 740 | (374) | 366 | 4,220 | (3,754) | 466 |
| Patents | 34,547 | (13,888) | 20,659 | 33,195 | (12,686) | 20,509 |
| Trademarks and trade names | 450 | (397) | 53 | 450 | (353) | 97 |
| Total intangible assets, net | $44,588 | $(19,914) | $24,674 | $46,366 | $(21,017) | $25,349 |
(1)This table excludes the gross value of fully amortized intangible assets totaling $49.3 million and $45.0 million at September 30, 2024 and December 31, 2023, respectively.
Amortization expense is recorded in selling, general and administrative expenses, except amortization expense related to capitalized software development costs, which is recorded in cost of sales. Amortization expense by statement of operations caption was as follows:
| (In thousands) · Three Months Ended September 30, · Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||
| Cost of sales | $207 | $146 | $488 | $302 |
| Selling, general and administrative expenses | 1,160 | 1,119 | 3,336 | 3,282 |
| Total amortization expense | $1,367 | $1,265 | $3,824 | $3,584 |
Estimated future annual amortization expense related to our intangible assets at September 30, 2024, was as follows:
| (In thousands) | |
|---|---|
| 2024 (remaining 3 months) | $1,369 |
| 2025 | 4,984 |
| 2026 | 4,420 |
| 2027 | 3,401 |
| 2028 | 2,780 |
| Thereafter | 7,720 |
| Total | $24,674 |
Note 7 —Leases
We have entered into various operating lease agreements for automobiles, offices and manufacturing facilities throughout the world. At September 30, 2024, our operating leases had remaining lease terms of up to 36 years, including any reasonably probable extensions.
Lease balances within our consolidated balance sheet were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Assets: | ||
| Operating lease right-of-use assets | $15,126 | $18,693 |
| Liabilities: | ||
| Other accrued liabilities | $4,155 | $4,813 |
| Long-term operating lease obligations | 9,409 | 12,560 |
| Total lease liabilities | $13,564 | $17,373 |
Operating lease expense, including variable and short-term lease costs which were insignificant to the total, operating lease cash
flows and supplemental cash flow information were as follows:
| (In thousands) · Three Months Ended September 30, · Nine Months Ended September 30, | ||||
|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||
| Cost of sales | $562 | $738 | $1,859 | $2,242 |
| Selling, general and administrative expenses | 1,112 | 1,030 | 3,365 | 3,215 |
| Total operating lease expense | $1,674 | $1,768 | $5,224 | $5,457 |
| Operating cash outflows from operating leases | $2,062 | $2,301 | $5,377 | $5,878 |
| Operating lease right-of-use assets obtained in exchange for lease obligations | $160 | $242 | $169 | $2,202 |
The weighted average remaining lease liability term and the weighted average discount rate were as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Weighted average lease liability term (in years) | 4.6 | 4.9 |
| Weighted average discount rate | 5.16% | 5.04% |
The following table reconciles the undiscounted cash flows for each of the first five years and thereafter to the operating lease liabilities recognized in our consolidated balance sheet at September 30, 2024. The reconciliation excludes short-term leases that are not recorded on the balance sheet.
| (In thousands) | September 30, 2024 |
|---|---|
| 2024 (remaining 3 months) | $1,014 |
| 2025 | 4,494 |
| 2026 | 3,491 |
| 2027 | 2,744 |
| 2028 | 1,253 |
| Thereafter | 2,498 |
| Total lease payments | 15,494 |
| Less: imputed interest | (1,930) |
| Total lease liabilities | $13,564 |
At September 30, 2024, we did not have any operating leases that had not yet commenced.
Note 8 —Lines of Credit
U.S. Line of Credit
On March 13, 2024, we executed an amendment to our Second Amended and Restated Credit Agreement ("Second Amended Credit Agreement") with U.S. Bank National Association ("U.S. Bank"), which provides for a revolving line of credit ("U.S. Credit Line") through April 30, 2025. We expect to renew our credit agreement with U.S. Bank prior to its expiration; however, no assurance can be given that future financing will be available or, if available, that we will be offered terms satisfactory to us. The U.S. Credit Line may be used for working capital and other general corporate purposes including acquisitions, share repurchases and capital expenditures.
The U.S. Credit Line has a maximum availability up to $100.0 million, subject to meeting certain financial conditions, including an accounts receivable coverage ratio ("AR Ratio"). This AR Ratio is calculated monthly and adjusts the current U.S. Credit Line total availability. At September 30, 2024, the U.S. Credit Line total availability was $65.6 million based upon the AR Ratio. At October 11, 2024, the U.S. Credit Line total availability was $67.0 million based upon the AR Ratio.
Amounts available for borrowing under the U.S. Credit Line are reduced by the balance of any outstanding letters of credit, of which there were none at September 30, 2024 and December 31, 2023.
All obligations under the U.S. Credit Line are secured by substantially all of our U.S. personal property and tangible and intangible assets, as well as a guaranty of the U.S. Credit Line by our wholly-owned subsidiary, Universal Electronics BV.
Under the Second Amended Credit Agreement, we may elect to pay interest on the U.S. Credit Line based on the Secured Overnight Financing Rate ("SOFR") plus a 3.00% margin. The amendment also introduces a facility fee of 0.25%. The interest rates in effect at September 30, 2024 and December 31, 2023 were 7.83% and 8.06%, respectively.
The Second Amended Credit Agreement includes financial covenants and contains other customary affirmative and negative covenants and events of default. From January 1, 2024 to September 30, 2024, our covenants are based upon EBITDA. From October 1, 2024 to December 31, 2024, our covenants will be based upon a minimum fixed charge coverage ratio. Subsequent to December 31, 2024, our covenants will be based upon a minimum fixed charge coverage ratio and a maximum cash flow leverage ratio. At September 30, 2024, we were in compliance with the covenants and conditions of the Second Amended Credit Agreement.
At September 30, 2024 and December 31, 2023, we had $37.0 million and $55.0 million outstanding under the U.S. Credit Line, respectively. At September 30, 2024, our remaining availability under our U.S. Credit Line was $28.6 million. Our total interest expense on borrowings under the U.S. Credit Line was $1.0 million and $1.6 million during the three months ended September 30, 2024 and 2023, respectively. Our total interest expense on borrowings under the U.S. Credit Line was $3.5 million and $4.5 million during the nine months ended September 30, 2024 and 2023, respectively.
China Line of Credit
On August 29, 2024, our subsidiary Gemstar Technology (Yangzhou) Co. Ltd. ("GTY"), executed a Line of Credit Agreement (the "Line of Credit Agreement") with the Bank of China, which provides for a revolving line of credit ("China Credit Line") through July 24, 2025. We expect to renew our Line of Credit Agreement with the Bank of China prior to its expiration; however, no assurance can be given that future financing will be available or, if available, that we will be offered terms satisfactory to us. The China Credit Line may be used for working capital purposes.
The China Credit Line has a maximum availability up to RMB 80.0 million (approximately $11.4 million), subject to meeting certain financial conditions.
Amounts available for borrowing under the China Credit Line are reduced by the balance of any outstanding letters of credit, of which there were none at September 30, 2024.
All obligations under the China Credit Line are secured by the mortgage of GTY's buildings and land use rights.
Under the Line of Credit Agreement, we may elect to pay interest on the China Credit Line based on the one-year rate from the National Interbank Funding Center less a 0.1% margin. There are no associated commitment fees on the China Credit Line. The interest rate in effect at September 30, 2024 was 3.10%.
The Line of Credit Agreement includes financial covenants and contains other customary affirmative and negative covenants and events of default. Our covenants are based on a debt to asset ratio and a dividends paid to net income ratio. At September 30, 2024, we were in compliance with the covenants and conditions of the Line of Credit Agreement.
At September 30, 2024, we had RMB 20.0 million (approximately $2.9 million) outstanding under the China Credit Line. At September 30, 2024, our remaining availability under our China Credit Line was RMB 60.0 million (approximately $8.6 million). Our total interest expense on borrowings under the China Credit Line was RMB 20.7 thousand (approximately $3.0 thousand) during the three and nine months ended September 30, 2024.
Note 9 —Income Taxes
We recorded income tax expense of $2.5 million and $3.3 million for the three months ended September 30, 2024 and 2023, respectively. We recorded income tax expense of $6.0 million and $3.4 million for the nine months ended September 30, 2024 and 2023, respectively. The income tax expense recorded for the nine months ended September 30, 2024 and 2023 is primarily attributable to the mix of pre-tax income among jurisdictions, including losses not benefited as a result of a valuation allowance.
The difference between the Company's effective tax rate and the 21.0% U.S. federal statutory rate for the nine months ended September 30, 2024 primarily related to the mix of pre-tax income and loss among jurisdictions and permanent tax items, including a tax on global intangible low-taxed income. The Company's income tax provision can be affected by other factors, including changes in the tax laws and regulations in the jurisdictions in which we operate, changes in the valuation allowances on deferred tax assets, and other discrete items.
At December 31, 2023, we assessed the realizability of the Company's deferred tax assets by considering whether it is more likely than not some portion or all of the deferred tax assets will not be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. We considered the scheduled reversal of deferred tax liabilities, tax planning strategies and projected future taxable income in making this assessment. At December 31, 2023, we had a three-year cumulative operating loss for our U.S. operations and, accordingly, have provided a full valuation allowance on our U.S. federal and state deferred tax assets. During the nine months ended September 30, 2024, there was no change to our U.S. valuation allowance position.
At September 30, 2024, we had gross unrecognized tax benefits of $3.5 million, including interest and penalties, which, if not for the valuation allowance recorded against the state Research and Experimentation income tax credit, would affect the annual effective tax rate if these tax benefits are realized. Further, we are unaware of any positions for which it is reasonably possible that the total amounts of unrecognized tax benefits will significantly increase within the next twelve months. Based on U.S. federal, state and foreign statute expirations in various jurisdictions, we do not anticipate a decrease in unrecognized tax benefits within the next twelve months. We have classified uncertain tax positions as non-current income tax liabilities unless they are expected to be paid within one year.
We have elected to classify interest and penalties as a component of tax expense. Accrued interest and penalties are immaterial at September 30, 2024 and December 31, 2023 and are included in the unrecognized tax benefits.
Note 10 —Accrued Compensation
The components of accrued compensation were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Accrued bonus | $1,994 | $2,843 |
| Accrued commission | 1,061 | 602 |
| Accrued salary/wages (1) | 5,041 | 4,085 |
| Accrued social insurance (2)(3) | 7,022 | 7,082 |
| Accrued vacation/holiday | 3,368 | 3,252 |
| Other accrued compensation | 2,150 | 2,441 |
| Total accrued compensation | $20,636 | $20,305 |
(1)Includes $0.6 million of accrued severance expenses at September 30, 2024 related to our Mexico manufacturing footprint optimization efforts. See Note 12 for further information related to our restructuring activities.
(2)Includes $17 thousand and $0.1 million of accrued severance expenses at September 30, 2024 and December 31, 2023, respectively, related to our Asia manufacturing footprint optimization efforts. See Note 12 for further information related to our restructuring activities.
(3)PRC employers are required by law to remit the applicable social insurance payments to their local government. Social insurance is comprised of various components such as pension, medical insurance, job injury insurance, unemployment insurance, and a housing assistance fund, and is administered in a manner similar to social security in the United States. This amount represents our estimate of the amounts due to the PRC government for social insurance on September 30, 2024 and December 31, 2023.
Note 11 —Other Accrued Liabilities
The components of other accrued liabilities were as follows:
| (In thousands) | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Contract liabilities | $3,324 | $2,697 |
| Duties | 585 | 481 |
| Expense associated with fulfilled performance obligations | 565 | 1,092 |
| Freight and handling fees | 2,052 | 1,998 |
| Interest | 2 | 438 |
| Operating lease obligations | 4,155 | 4,813 |
| Product warranty claims costs | 497 | 522 |
| Professional fees | 1,925 | 1,558 |
| Sales and value added taxes | 1,456 | 4,194 |
| Other (1) | 4,075 | 3,388 |
| Total other accrued liabilities | $18,636 | $21,181 |
(1)Includes $0.4 million and $0.2 million at September 30, 2024 and December 31, 2023, respectively, associated with the purchase of property, plant and equipment.
Note 12 —Commitments and Contingencies
Product Warranties
Changes in the liability for product warranty claims costs were as follows:
| (In thousands) | Nine Months Ended September 30, | |
|---|---|---|
| 2024 | 2023 | |
| Balance at beginning of period | $522 | $522 |
| Accruals for warranties issued during the period | 78 | — |
| Settlements (in cash or in kind) during the period | (103) | — |
| Foreign currency translation gain (loss) | — | — |
| Balance at end of period | $497 | $522 |
Restructuring Activities
Asia
In conjunction with our plan to restructure and optimize our manufacturing footprint while reducing our concentration risk in the PRC, we stopped all production activities and began to shut down our southwestern China factory beginning in the third quarter of 2023. We incurredno severance or other exit costs during the three months ended September 30, 2024 and $3.4 million of severance and $0.3 million of other exit costs for the three months ended September 30, 2023. We incurred $0.1 million of severance and $0.1 million of other exit costs during the nine months ended September 30, 2024 and $3.4 million of severance and $0.3 million of other exit costs for the nine months ended September 30, 2023. These costs are included within factory restructuring charges on our consolidated statements of operations. We have recognized a total of $4.2 million in factory restructuring charges since September 2023. This factory restructuring was completed in the second quarter of 2024 and we do not expect any further expenses associated with this plan.
Mexico
As part of our plan to restructure and optimize our factory footprint, we are working to downsize our factory in Mexico due to decreased demand in the U.S. market and our Vietnam facility's ability to supply our North American customers. We have leased a smaller facility and reduced our factory headcount during the nine months ended September 30, 2024. We revised our severance accrual downward by $0.1 million and incurred $0.2 million of other exit costs during the three months ended September 30, 2024. We incurred $1.3 million of severance and $1.3 million of other exit costs during the nine months ended September 30, 2024. These costs are included within factory restructuring charges on our consolidated statements of operations. We expect this factory restructuring to be completed in the fourth quarter of 2024 with total estimated restructuring charges of $2.6 million, including $41.0 thousand expected to be recognized subsequent to September 30, 2024.
Restructuring liabilities are included in accrued compensation, accounts payable and other accrued liabilities on our consolidated balance sheets. Total restructuring activities for the nine months ended September 30, 2024 are as follows:
| Restructuring Costs | |||
|---|---|---|---|
| (In thousands) | Total | SeveranceExpense | Other ExitExpense |
| Balance at December 31, 2023 | $462 | $147 | $315 |
| Restructuring charges | 2,723 | 1,356 | 1,367 |
| Cash payments | (2,278) | (898) | (1,380) |
| Balance at September 30, 2024 | $907 | $605 | $302 |
| Total costs incurred inception to date | $6,738 | $4,781 | $1,957 |
| Total remaining expected expense to be incurred as of September 30, 2024 | $41 | $— | $41 |
Litigation
Roku Matters
2018 Lawsuit
On September 5, 2018, we filed a lawsuit against Roku, Inc. ("Roku") in the United States District Court, Central District of California, alleging that Roku is willfully infringing nine of our patents that are infour patent families related to remote control set-up and touchscreen remotes. On December 5, 2018, we amended our complaint to add additional details supporting our infringement and willfulness allegations. We have alleged that this complaint relates to multiple Roku streaming players and components therefor and certain universal control devices, including but not limited to the Roku App, Roku TV, Roku Express, Roku Streaming Stick, Roku Ultra, Roku Premiere, Roku 4, Roku 3, Roku 2, Roku Enhanced Remote and any other Roku product that provides for the remote control of an external device such as a TV, audiovisual receiver, sound bar or Roku TV Wireless Speakers. In October 2019, the Court stayed this lawsuit pending action by the Patent Trial and Appeals Board (the "PTAB") with respect to Roku's requests for Inter Partes Review ("IPR") and with respect to the International Trade Commission Investigation. At this time, we are only waiting for the decision of the U.S. Supreme Court with respect to Roku's appeal request (see discussion below) and once received, we expect to be able to ask the District Court to lift this stay.
International Trade Commission Investigation of Roku, TCL, Hisense and Funai
On April 16, 2020, we filed a complaint with the International Trade Commission (the "ITC") against Roku, TCL Electronics Holding Limited and related entities (collectively, "TCL"), Hisense Co., Ltd. and related entities (collectively, "Hisense"), and Funai Electric Company, Ltd. and related entities (collectively, "Funai") claiming that certain of their televisions, set-top boxes, remote control devices, human interface devices, streaming devices, and sound bars infringe certain of our patents. We asked the ITC to issue a permanent limited exclusion order prohibiting the importation of these infringing products into the United States and a cease and desist order to stop these parties from continuing their infringing activities. On May 18, 2020, the ITC announced that it instituted its investigation as requested by us. Prior to the trial, which ended on April 23, 2021, we dismissed
TCL, Hisense and Funai from this investigation as they either removed or limited the amount of our technology from their televisions as compared to our patent claims that we asserted at the time. On July 9, 2021, the Administrative Law Judge (the "ALJ") issued his Initial Determination (the "ID") finding that Roku is infringing our patents and as a result is in violation of §337 of the Tariff Act of 1930, as amended (the "Tariff Act"). On July 23, 2021, Roku and we filed petitions to appeal certain portions of the ID. On November 10, 2021, the full ITC issued its final determination affirming the ID and issuing a Limited Exclusion Order (the "LEO") and Cease and Desist Order (the "CDO") against Roku, which became effective on January 9, 2022. In January 2022, Roku filed its appeal of the ITC ruling with the U.S. Court of Appeals for the Federal Circuit (the "USCAFC"). Oral argument for this appeal was held on September 5, 2023 and in January 2024 the USCAFC issued its decision affirming the ITC ruling in full. On March 4, 2024, Roku filed a petition for rehearing and rehearing en banc and on April 3, 2024, the USCAFC denied Roku’s petition. In June 2024, Roku advised us that they would file an appeal of the adverse ruling against them in this investigation to the U.S. Supreme Court, and on June 12, 2024, Roku filed an application seeking a 45-day extension (to August 16, 2024) to file their Writ of Certiorari. This extension was approved. Initially, we opted to waive our right to file a response to Roku’s Writ, however, the U.S. Supreme Court requested our response. We have until November 27, 2024 to file our response. Thereafter, we expect the U.S. Supreme Court to make its decision whether or not to hear Roku’s appeal.
2020 Lawsuit
As a companion case to our ITC complaint, on April 9, 2020, we filed separate actions against each of Roku, TCL, Hisense, and Funai in the United States District Court, Central District of California, alleging that Roku is willfully infringing five of our patents and TCL, Hisense, and Funai are willfully infringingsix of our patents by incorporating our patented technology into certain of their televisions, set-top boxes, remote control devices, human interface devices, streaming devices and sound bars. The Court stayed this lawsuit pending action by the PTAB with respect to Roku's requests for IPR and with respect to the International Trade Commission Investigation. At this time, we are only waiting for the decision of the U.S. Supreme Court with respect to Roku’s appeal request (see discussion above) and once received, we expect to be able to ask the District Court to lift this stay.
Inter Partes Reviews
Throughout these litigation matters against Roku and the others identified above, Roku has filed multiple IPR requests with the PTAB on all patents at issue in the 2018 Lawsuit, the ITC Action, and the 2020 Lawsuit (see discussion above). To date, the PTAB has denied Roku's request fourteen times, and granted Roku's request twelve times. Roku has since filedtwo IPRs ontwo of our patents not yet asserted against it, and we are awaiting the PTAB's institution decision with respect to those new IPR requests. Of thetwelve IPR requests granted by the PTAB, the results were mixed, with the PTAB upholding the validity of many of our patent claims and invalidating others. Most of these PTAB actions have been completed, and as soon as we learn the decision of the U.S. Supreme Court, we expect to be able to petition the District Court to lift the stay on the 2018 and 2020 cases.
International Trade Commission Investigation Request Made by Roku against UEI and certain UEI Customers
On April 8, 2021, Roku made a request to the ITC to initiate an investigation against us and certain of our customers claiming that certain of our and those customers' remote control devices and televisions infringetwo of Roku's recently acquired patents, the '511 patent and the '875 patent. On May 10, 2021, the ITC announced its decision to initiate the requested investigation. Immediately prior to trial Roku stipulated to summary determination as to its complaint against us andtwo of our customers with respect toone of thetwo patents at issue. This stipulation resulted in the complaint against us andtwo of our customers with respect to that patent not going to trial. The trial was thus shortened and ended on January 24, 2022. On June 24, 2022, the ALJ, pursuant to Roku's stipulation, found the '511 patent invalid as indefinite. Thereafter, on June 28, 2022, the ALJ issued an ID fully exonerating us and our customers finding the '875 patent invalid and that Roku failed to prove it established the requisite domestic industry and thus no violation of the Tariff Act. In advance of the full Commission's review, Roku and we filed petitions to appeal certain portions of the ID. In addition, the PTAB granted our request for an IPR with respect to the '875 patent. On October 28, 2022, the full ITC issued its final determination affirming the ID, ruling there was no violation of the Tariff Act and terminated the investigation. In December 2022, Roku filed an appeal, which remains pending. In addition, Roku, along with the ITC, filed a joint motion to dismiss the '511 patent as moot as it recently expired. We are opposing this motion. Further, on October 23, 2023, the PTAB issued its Final Written Decision invalidating all of the claims Roku alleges we infringe. As a companion to its ITC request, on April 8, 2021, Roku also filed a lawsuit against us in Federal District Court in the Central District of California alleging that we are infringing the sametwo patents they alleged being infringed in the ITC investigation explained above. This District Court case has been stayed pending the ITC case, and will likely continue to be stayed pending the conclusion of Roku's appeal of the ITC case.
Court of International Trade Action against the United States of America, et. al.
On October 9, 2020, we and our subsidiaries, Ecolink Intelligent Technology, Inc. ("Ecolink") and RCS Technology, LLC ("RCS"), filed an amended complaint (20-cv-00670) in the Court of International Trade (the "CIT") against the United States of America; the Office of the United States Trade Representative; Robert E. Lighthizer, U.S. Trade Representative; U.S. Customs & Border Protection; and Mark A. Morgan, U.S. Customs & Border Protection Acting Commissioner, challenging both the substantive and procedural processes followed by the United States Trade Representative ("USTR") when instituting Section 301 Tariffs on imports from China under Lists 3 and 4A.
Pursuant to this complaint, Ecolink, RCS and we are alleging that USTR's institution of Lists 3 and 4A tariffs violated the Trade Act of 1974 (the "Trade Act") on the grounds that the USTR failed to make a determination or finding that there was an unfair trade practice that required a remedy and moreover, that Lists 3 and 4A tariffs were instituted beyond the 12-month time limit provided for in the governing statute. Ecolink, RCS and we also allege that the manner in which the Lists 3 and 4A tariff actions were implemented violated the Administrative Procedures Act (the "APA") by failing to provide adequate opportunity for comments, failing to consider relevant factors when making its decision and failing to connect the record facts to the choices it made by not explaining how the comments received by USTR came to shape the final implementation of Lists 3 and 4A.
Ecolink, RCS and we are asking the CIT to declare that the defendants' actions resulting in the tariffs on products covered by Lists 3 and 4A are unauthorized by and contrary to the Trade Act and were arbitrarily and unlawfully promulgated in violation of the APA; to vacate the Lists 3 and 4A tariffs; to order a refund (with interest) of any Lists 3 and 4A duties paid by Ecolink, RCS and us; to permanently enjoin the U.S. government from applying Lists 3 and 4A duties against Ecolink, RCS and us; and award Ecolink, RCS and us our costs and reasonable attorney's fees.
In July 2021, the CIT issued a preliminary injunction suspending liquidation of all unliquidated entries subject to Lists 3 and 4A duties and has asked the parties to develop a process to keep track of the entries to efficiently and effectively deal with liquidation process and duties to be paid or refunded when finally adjudicated. On February 5, 2022, the CIT heard oral arguments on dispositive motions filed on behalf of plaintiffs and defendants. On April 1, 2022, the CIT issued its opinion on these dispositive motions, ruling that the USTR had the legal authority to promulgate List 3 and List 4A under Section 307(a)(1)(B) of the Trade Act, but that the USTR violated the APA when it promulgated List 3 and List 4A concluding that the USTR failed to adequately explain its decision as required under the APA. The Court ordered that List 3 and List 4A be remanded to the USTR for reconsideration or further explanation regarding its rationale for imposing the tariffs. The Court declined to vacate List 3 and List 4A, which means that they are still in place while on remand. The Court's preliminary injunction regarding liquidation of entries also remains in effect. The Court initially set a deadline of June 30, 2022, for the USTR to complete this process, which was extended to August 1, 2022.
On August 1, 2022, the USTR provided the Court with that further explanation and also purported to respond to the significant comments received during the original notice-and-comment process. On September 14, 2022, the lead plaintiff filed its comments to the USTR's August 1, 2022 filing, asserting that the USTR did not adequately respond to the Court's remand order and requested the Court to vacate the List 3 and List 4A tariffs and issue refunds immediately. On March 17, 2023, the CIT sustained the List 3 and List 4 tariffs, concluding that USTR’s rationale in support of the tariffs was not impermissibly post hoc. The Court also concluded that USTR adequately explained its reliance on presidential direction and adequately responded to significant comments regarding the harm to the U.S. economy, efficacy of the tariffs, and alternatives to the tariffs. Lead plaintiffs have appealed this decision. The parties have fully briefed their positions on this appeal and oral argument is expected to be set for later in 2024 and a decision sometime in 2025.
Tongshun Matters
On January 23, 2024, Tongshun Company ("TS") filed suit against one of our subsidiaries, GTY, claiming among other things, breach of an employment agency contract, and as is standard in Chinese litigation matters such as these, TS has also requested the court to order a hold on GTY's bank account for the total claimed amount of RMB 35 million. This asset protection order is a standard request and routinely granted. On February 5, 2024, we learned that the court accepted the lawsuit filed by TS. On
February 8, 2024, we deposited RMB 35 million (approximately $5.0 million) with the court. On July 12, 2024, we were refunded RMB 10 million (approximately $1.4 million) of the original deposit. This deposit is included in prepaid expenses and other current assets on our consolidated balance sheets. We have ongoing settlement discussions and while such discussions continue, the hearing on this matter has been stayed.
There are no other material pending legal proceedings to which we or any of our subsidiaries is a party or of which our respective property is the subject. However, as is typical in our industry and to the nature and kind of business in which we are engaged, from time to time, various claims, charges and litigation are asserted or commenced by third parties against us or by us against third parties arising from or related to product liability, infringement of patent or other intellectual property rights, breach of warranty, contractual relations, or employee relations. The amounts claimed may be substantial, but may not bear any reasonable relationship to the merits of the claims or the extent of any real risk of court awards assessed against us or in our favor. However, no assurances can be made as to the outcome of any of these matters, nor can we estimate the range of potential losses to us. In our opinion, final judgments, if any, which might be rendered against us in potential or pending litigation would not have a material adverse effect on our consolidated financial condition, results of operations, or cash flows. Moreover, we believe that our products do not infringe any third parties' patents or other intellectual property rights.
We maintain directors' and officers' liability insurance which insures our individual directors and officers against certain claims, as well as attorney's fees and related expenses incurred in connection with the defense of such claims.
Note 13 —Treasury Stock
From time to time, our Board of Directors authorizes management to repurchase shares of our issued and outstanding common stock. On October 26, 2023, our Board approved a share repurchase program with an effective date of November 7, 2023 (the "October 2023 Program"). Pursuant to the October 2023 Program, we are authorized to repurchase up to 1,000,000 shares of our common stock. At September 30, 2024, we had 778,362 shares available for repurchase under the October 2023 Program. Per the terms of the October 2023 Program, we may utilize various methods to effect the repurchases, including open market repurchases, negotiated block transactions, accelerated share repurchases or open market solicitations for shares, some or all of which could be effected through Rule 10b5-1 plans.
We also repurchase shares of our issued and outstanding common stock to satisfy the cost of stock option exercises and/or income tax withholding obligations relating to the stock-based compensation of our employees and directors.
Repurchased shares of our common stock were as follows:
| Nine Months Ended September 30, | ||
|---|---|---|
| (In thousands) | 2024 | 2023 |
| Open market shares repurchased | 122 | — |
| Stock-based compensation related shares repurchased | 79 | 61 |
| Total shares repurchased | 201 | 61 |
| Cost of open market shares repurchased | $1,109 | $— |
| Cost of stock-based compensation related shares repurchased | 787 | 888 |
| Total cost of shares repurchased | $1,896 | $888 |
Repurchased shares are recorded as shares held in treasury at cost. We hold these shares for future use as management and the Board of Directors deem appropriate.
Note 14 —Stock-Based Compensation
Stock-based compensation expense for each employee and director is presented in the same statement of operations caption as their cash compensation. Stock-based compensation expense by statement of operations caption and the related income tax benefit were as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2024 | 2023 |
| Cost of sales | $25 | $32 | $72 | $94 |
| Research and development expenses | 198 | 283 | 571 | 817 |
| Selling, general and administrative expenses: | ||||
| Employees | 1,321 | 1,726 | 4,076 | 5,398 |
| Outside directors | 107 | 94 | 296 | 524 |
| Total employee and director stock-based compensation expense | $1,651 | $2,135 | $5,015 | $6,833 |
| Income tax benefit | $255 | $326 | $762 | $1,073 |
Restricted Stock
Non-vested restricted stock award activity was as follows:
| Shares(in thousands) | Weighted-Average Grant Date Fair Value | |
|---|---|---|
| Non-vested at December 31, 2023 | 486 | $21.66 |
| Granted | 355 | 10.46 |
| Vested | (242) | 25.11 |
| Forfeited | (18) | 16.40 |
| Non-vested at September 30, 2024 | 581 | $13.51 |
As of September 30, 2024, we expect to recognize $6.0 million of total unrecognized pre-tax stock-based compensation expense related to non-vested restricted stock awards over a weighted-average life of 1.8 years.
Performance Stock
Non-vested performance stock award activity was as follows:
| Shares(in thousands) | Weighted-Average Grant Date Fair Value | |
|---|---|---|
| Non-vested at December 31, 2023 | — | $— |
| Granted | 116 | 4.72 |
| Vested | — | — |
| Forfeited | — | — |
| Non-vested at September 30, 2024 | 116 | $4.72 |
The assumptions we utilized in the Monte Carlo simulation model and the resulting weighted average fair value of performance stock grants were the following:
| Three Months Ended September 30, | Nine Months Ended September 30, | |
|---|---|---|
| 2024 | 2024 | |
| Weighted average fair value of grants | $— | $4.72 |
| Risk-free interest rate | —% | 4.08% |
| Expected volatility | —% | 57.00% |
| Expected life in years | 0.00 | 2.73 |
As of September 30, 2024, we expect to recognize $0.4 million of total unrecognized pre-tax stock-based compensation expense related to non-vested performance stock awards over a weighted-average life of 2.1 years.
Stock Options
Stock option activity was as follows:
| Number of Options(in thousands) | Weighted-Average Exercise Price | Weighted-Average Remaining Contractual Term(in years) | Aggregate Intrinsic Value(in thousands) | |
|---|---|---|---|---|
| Outstanding at December 31, 2023 | 901 | $38.78 | ||
| Granted | — | — | ||
| Exercised | — | — | $— | |
| Forfeited/canceled/expired | (122) | 58.52 | ||
| Outstanding at September 30, 2024 (1) | 779 | $35.67 | 3.37 | $— |
| Vested and expected to vest at September 30, 2024 (1) | 779 | $35.67 | 3.37 | $— |
| Exercisable at September 30, 2024 (1) | 646 | $37.63 | 2.96 | $— |
(1)The aggregate intrinsic value represents the total pre-tax value (the difference between our closing stock price on the last trading day of the third quarter of 2024 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had they all exercised their options on September 30, 2024. This amount will change based on the fair market value of our stock.
The assumptions we utilized in the Black-Scholes option pricing model and the resulting weighted average fair value of stock option grants were the following:
| Three Months Ended September 30, | Nine Months Ended September 30, | |
|---|---|---|
| 2023 | 2023 | |
| Weighted average fair value of grants | $— | $10.83 |
| Risk-free interest rate | —% | 3.86% |
| Expected volatility | —% | 45.89% |
| Expected life in years | 0.00 | 4.70 |
As of September 30, 2024, we expect to recognize $1.3 million of total unrecognized pre-tax stock-based compensation expense related to non-vested stock options over a remaining weighted-average life of 1.2 years.
Note 15 —Other Income (Expense), Net
Other income (expense), net consisted of the following:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2024 | 2023 |
| Net gain (loss) on foreign currency exchange contracts (1) | $374 | $19 | $159 | $(2,788) |
| Net gain (loss) on foreign currency exchange transactions | (108) | (1,085) | (351) | 545 |
| Other income (expense) | 8 | 215 | 297 | 476 |
| Other income (expense), net | $274 | $(851) | $105 | $(1,767) |
(1)This represents the gains (losses) incurred on foreign currency hedging derivatives (see Note 17 for further details).
Note 16 —Earnings (Loss) Per Share
Earnings (loss) per share was calculated as follows:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands, except per-share amounts) | 2024 | 2023 | 2024 | 2023 |
| BASIC | ||||
| Net income (loss) | $(2,658) | $(19,362) | $(19,500) | $(91,136) |
| Weighted-average common shares outstanding | 12,985 | 12,911 | 12,935 | 12,839 |
| Basic earnings (loss) per share | $(0.20) | $(1.50) | $(1.51) | $(7.10) |
| DILUTED | ||||
| Net income (loss) | $(2,658) | $(19,362) | $(19,500) | $(91,136) |
| Weighted-average common shares outstanding for basic | 12,985 | 12,911 | 12,935 | 12,839 |
| Dilutive effect of stock options, restricted stock and performance stock | — | — | — | — |
| Weighted-average common shares outstanding on a diluted basis | 12,985 | 12,911 | 12,935 | 12,839 |
| Diluted earnings (loss) per share | $(0.20) | $(1.50) | $(1.51) | $(7.10) |
The following number of stock options, shares of restricted stock and shares of performance stock were excluded from the computation of diluted earnings per common share as their inclusion would have been anti-dilutive:
| Three Months Ended September 30, | Nine Months Ended September 30, | |||
|---|---|---|---|---|
| (In thousands) | 2024 | 2023 | 2024 | 2023 |
| Stock options | 779 | 925 | 802 | 892 |
| Restricted stock awards | 586 | 513 | 511 | 421 |
| Performance stock awards | 116 | — | 101 | — |
Note 17 —Derivatives
The following table sets forth the total net fair value of derivatives:
| September 30, 2024 · December 31, 2023 | ||||||||
|---|---|---|---|---|---|---|---|---|
| Fair Value Measurement Using · Total Balance · Fair Value Measurement Using · Total Balance | ||||||||
| (In thousands) · Level 1 · Level 2 · Level 3 · Level 1 · Level 2 · Level 3 | ||||||||
| Foreign currency exchange contracts | $— | $337 | $— | $337 | $— | $(83) | $— | $(83) |
We held foreign currency exchange contracts, which resulted in a net pre-tax gain of $0.4 million and net pre-tax gain of $19 thousand for the three months ended September 30, 2024 and 2023, respectively. For the nine months ended September 30, 2024 and 2023, we had a net pre-tax gain of $0.2 million and a net pre-tax loss of $2.8 million, respectively.
Details of foreign currency exchange contracts held were as follows:
| Date Held | Currency | Position Held | Notional Value(in millions) | Forward Rate | Unrealized Gain/(Loss) Recorded at Balance SheetDate(in thousands)(1) | Settlement Date |
|---|---|---|---|---|---|---|
| September 30, 2024 | USD/Chinese Yuan Renminbi | CNY | $25.0 | 7.0991 | $330 | October 8, 2024 |
| September 30, 2024 | USD/Euro | USD | $9.0 | 1.1141 | $7 | October 4, 2024 |
| December 31, 2023 | USD/Chinese Yuan Renminbi | CNY | $20.0 | 7.1181 | $(18) | January 5, 2024 |
| December 31, 2023 | USD/Euro | USD | $22.0 | 1.1009 | $(65) | January 5, 2024 |
(1)Unrealized gains on foreign currency exchange contracts are recorded in prepaid expenses and other current assets. Unrealized losses on foreign currency exchange contracts are recorded in other accrued liabilities.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.